TYRLIBRIA
Dead / Abandoned — Abandoned — no statement of use filed (as of 07 Mar 2022)
What this means for you
This application is over — abandoned 07 Mar 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88818863
- Mark type
- Stylized text
- Filed
- 03 Mar 2020
- Published for opposition
- 09 Jun 2020
- Abandoned
- 07 Mar 2022
- Attorney of record
- John Paul Oleksiuk
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of dry eye disease; Pharmaceutical preparations for the treatment of neurotropic keratitis; pharmaceutical preparations for the treatment of ophthalmological diseases; nasal spray preparations; pharmaceutical preparations in the form of nasal sprays for the treatment of ophthalmological diseases
Owner
- Oyster Point Pharma, Inc., Princeton, NJ, US
- Oyster Point Pharma, Inc., Princeton, NJ, US
Prosecution history
- 07 Mar 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 07 Mar 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 17 Jun 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Jun 2021 — SOU EXTENSION 2 GRANTED
- 15 Jun 2021 — SOU EXTENSION 2 FILED
- 15 Jun 2021 — SOU TEAS EXTENSION RECEIVED
- 23 Jan 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Jan 2021 — SOU EXTENSION 1 GRANTED
- 21 Jan 2021 — SOU EXTENSION 1 FILED
- 21 Jan 2021 — SOU TEAS EXTENSION RECEIVED
- 04 Aug 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 09 Jun 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Jun 2020 — PUBLISHED FOR OPPOSITION
- 20 May 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Apr 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER